<p>The median overall survival was significantly shorter in the progressive disease (PD) group than in the partial response (PR) + stable disease (SD) group (134 days vs. 378 days; p<0.0001).</p
<p>Survival according to time to diagnosis (more or less than the median of 65 days).</p
<p>Survival was longer in MyD88 (B) negative cases (by 19 months; p<0.05). The difference in surviva...
<p>The low risk group showed significant differences compared with the intermediate and high risk gr...
<p>In the poor prognostic score 4, 3 or 2 groups, the median overall survival was significantly shor...
<p>The median overall survival was significantly shorter in the high alpha-fetoprotein (AFP) ratio g...
<p>Probability of overall survival after start of treatment in patients with disease control (SD+PR)...
<p>There were significant differences in the cumulative overall survival of patients among the five ...
<p>The median overall survival was significantly shorter in the liver function deterioration group t...
<p>The overall survival (OS) of the patients who reached CR; or achieved the other response (PR or m...
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>The cumulative survival rate was compared in patients with CRP ≤ 0.8 mg/L and those with CRP > 0....
<p>The median overall survival was significantly shorter in the intra-tumor blood flow non-disappear...
After 5 years’ follow-up, group 1 had lower cumulative survival rate than the other two groups (i.e....
<p>Comparison of the survival curves of the 119 cases treated with PD combined with vascular resecti...
<p>There was statistically significant difference in the survival rate (Log rank P = 0.001).</p
<p>Survival according to time to diagnosis (more or less than the median of 65 days).</p
<p>Survival was longer in MyD88 (B) negative cases (by 19 months; p<0.05). The difference in surviva...
<p>The low risk group showed significant differences compared with the intermediate and high risk gr...
<p>In the poor prognostic score 4, 3 or 2 groups, the median overall survival was significantly shor...
<p>The median overall survival was significantly shorter in the high alpha-fetoprotein (AFP) ratio g...
<p>Probability of overall survival after start of treatment in patients with disease control (SD+PR)...
<p>There were significant differences in the cumulative overall survival of patients among the five ...
<p>The median overall survival was significantly shorter in the liver function deterioration group t...
<p>The overall survival (OS) of the patients who reached CR; or achieved the other response (PR or m...
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>The cumulative survival rate was compared in patients with CRP ≤ 0.8 mg/L and those with CRP > 0....
<p>The median overall survival was significantly shorter in the intra-tumor blood flow non-disappear...
After 5 years’ follow-up, group 1 had lower cumulative survival rate than the other two groups (i.e....
<p>Comparison of the survival curves of the 119 cases treated with PD combined with vascular resecti...
<p>There was statistically significant difference in the survival rate (Log rank P = 0.001).</p
<p>Survival according to time to diagnosis (more or less than the median of 65 days).</p
<p>Survival was longer in MyD88 (B) negative cases (by 19 months; p<0.05). The difference in surviva...
<p>The low risk group showed significant differences compared with the intermediate and high risk gr...